pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol NIPBL   
Synonyms CDLS, CDLS1, IDN3, IDN3-B, Scc2
Description NIPBL, cohesin loading factor
Transcript NM_015384   
Other Transcripts NM_133433   
Expression
Putative miRNA Targets on NIPBL
3'UTR of NIPBL
(miRNA target sites are highlighted)
>NIPBL|NM_015384|3'UTR
   1 AATGATTTTTATGTGCTTATATATGTCAGTCTATTAAATGTACACCAAGTAATGTAATACTTAAAAGAGAAAACATTTTG
  81 TAGATAGAGATTCTCTACTTACCCGTTTATACATCCTTTTGTAGAAAGTTTAACATAAAAGACAATAAAAAAACAGAAAT
 161 GAGATTTATCCAGCATAAAGGGTTAATTTTTCTTTGAATTGTATTAATGTGTGTTATTTTTATTGTTGCTAAGTTTTATG
 241 TAGCTATATGGTTCATATGTATATATAATTTTATATATCAATAAGAGTAAAGACACGGGTACAAATTAAGAGTTATATGG
 321 TTTTACAAGTATATGTTAACCCCTTGGCGCTGGCGGTCACGGTGCGTCTCATTGCCGGCAATGGAAGTGTGCCGGGAAAT
 401 CCCAACTCCCGGCGTCAAGGGATTAAAAGCAATAAAAACAATAATTTCACTAAAATTCTTTTGTGTAACACTTGGTCTTT
 481 TTTCCCCCCTCCCAATGTTTTAGTCATTGAGAAGGTCAAAACGAAATTCAGACTCTACGGAGTTGGCAGCACAGATGAAT
 561 GAAAGTGTTGACGTCATGGATGTCATCGCTATTTGCTGTCCAAAGTACAAAGATCGACCACAAATTGCAAGAGTAGTGCA
 641 GAAAACCAGCAGTGGCTTCAGTGTTCAGTGGATGGCAGGCTCCTACAGTGGCTCCTGGACTGAGGCTAAGCGCCGTGATG
 721 GCCGCAAACTGGTGCCTTGGGTAGACACTATTAAAGAGTCAGACATTATTTACAAAAAAATTGCTCTAACGAGTGCTAAT
 801 AAGCTGACTAATAAAGTTGTTCAGACTTTACGATCCCTGTATGCCGCCAAGGATGGGACTTCCAGCTAATGAATTTGTAC
 881 ATGCAGCCAAATTTACAGGAATTTTTTTAAAAGGCAGAAAAACTTGAAATACCAACATTCTGGCAAAAAAAAATCAGTTT
 961 TATGAAGAGTAAGTGGAACCTGGGATGCAGGAACAAAAGAAGGAAATGTTGGGCAAACATTTTTGTGGGAGCTCCCTTCG
1041 CTGTTGTGCAGCAGAAACAGATTCTCAGTTCATTTTTACTCCCACTGTATTATAGTTTAACAAAAATTGTTTATATCTTG
1121 GAAAAAAAACTTTCTGTTTAAAAAAAATAAACAAGTGAATGTTGGAAATTAGTCTGTTAATGTTCTTAATAAAGTGTTCT
1201 TGGAGTTTAACCTAGCAGCGGATGGCTTTCTTTAGCTTAGCCCAGTTTCCAGGGAAGCATTGTTTTTTCCAGGCTGTAAA
1281 ATGGCAGAATCTCCTGGATATATAATTTATTCTGTTGAAAAAAAAAAAAGCATGCAGTATCTATGACCTATCTGCAGAAG
1361 GAGTTTTTGTAAATGTAGATTTTGATGTATTAGGTCACCCTGAAAACAATACAAGAAAAGGGATCCCCAGGTAATCTGGT
1441 GGAGCGAATACTGCAATAAATTTTTTTACTTCTCTTTGTTACTTGTCTGTTTCCATTTGAATTTCTTATTGTAAAAATCT
1521 GTTTAAATCCATTTATATTATTTTACAGTCTTTTATGTAAAATTTATTATATCACTGGTTTTCAAAGCAAAACATAAAAT
1601 ATTGTTTATACAGTTTGTATAGGCTGACTTCTGAATAATTGGTATCTATTATTTTCATTCCCATAAGAGGGTGTAAACAA
1681 TTAACTCCAGGGTTTTATTGTATCCTGCAATATTTAGTATTAACTATATATGATTTAGCACTGTGCCAAACACATTTTCA
1761 AGAGTACATTTTGATATAAAAAGAAACTATAGTTTA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agUCGGCGACAGUGUGCGUGUc 5'
            ||:  || |:| |:|:||| 
Target 5' tcAGT--CTATTAAATGTACAc 3'
26 - 45 124.00 -10.60
2
miRNA  3' agUCGGCGACAGUGUGCGUGUc 5'
            | ::||||||  | |:||| 
Target 5' ctATTTGCTGTCCAAAGTACAa 3'
589 - 610 120.00 -14.40
3
miRNA  3' agUCGGCG-AC--AGUGUGCGUGUc 5'
            |||: : ||  |||:|:|:|:| 
Target 5' gtAGCTATATGGTTCATATGTATAt 3'
240 - 264 114.00 -13.50
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
588686 540 ClinVar
904295 594 ClinVar
817851 601 ClinVar
770717 603 ClinVar
159241 619 ClinVar
167362 621 ClinVar
159242 628 ClinVar
159243 680 ClinVar
353390 691 ClinVar
972992 725 ClinVar
493407 726 ClinVar
159244 729 ClinVar
211665 729 ClinVar
211666 751 ClinVar
159245 753 ClinVar
1076024 774 ClinVar
864674 785 ClinVar
159246 791 ClinVar
586179 792 ClinVar
211667 797 ClinVar
976313 824 ClinVar
1183995 827 ClinVar
96355 832 ClinVar
524054 838 ClinVar
796301 846 ClinVar
159247 863 ClinVar
589346 869 ClinVar
905097 902 ClinVar
159023 945 ClinVar
211619 945 ClinVar
353391 1012 ClinVar
353392 1133 ClinVar
353393 1149 ClinVar
353394 1204 ClinVar
905098 1221 ClinVar
905099 1224 ClinVar
353395 1318 ClinVar
353396 1415 ClinVar
353397 1421 ClinVar
353398 1610 ClinVar
COSN28690169 157 COSMIC
COSN28188898 167 COSMIC
COSN30391158 197 COSMIC
COSN22840354 214 COSMIC
COSN19613646 393 COSMIC
COSN28777762 443 COSMIC
COSN5853864 484 COSMIC
COSN14167271 485 COSMIC
COSM3410253 522 COSMIC
COSM3947486 523 COSMIC
COSM3615964 524 COSMIC
COSM8379147 539 COSMIC
COSM2688096 548 COSMIC
COSM5472106 551 COSMIC
COSM1671594 563 COSMIC
COSM4585866 568 COSMIC
COSM8372288 571 COSMIC
COSM1671595 574 COSMIC
COSM8578285 579 COSMIC
COSM1620277 586 COSMIC
COSM8498500 587 COSMIC
COSM4898746 588 COSMIC
COSM1067739 589 COSMIC
COSM6504337 596 COSMIC
COSM5551960 615 COSMIC
COSM5931692 616 COSMIC
COSM5438473 617 COSMIC
COSM7107476 632 COSMIC
COSM9888354 634 COSMIC
COSM7544977 646 COSMIC
COSM4878526 650 COSMIC
COSM1671596 667 COSMIC
COSM2688102 672 COSMIC
COSM6295079 675 COSMIC
COSM1437316 676 COSMIC
COSM8202655 677 COSMIC
COSM6103735 724 COSMIC
COSM592268 725 COSMIC
COSM3365771 729 COSMIC
COSM5627365 754 COSMIC
COSM1181004 781 COSMIC
COSM5006083 782 COSMIC
COSM6726421 787 COSMIC
COSM9222115 793 COSMIC
COSM6999987 794 COSMIC
COSM8859098 804 COSMIC
COSM1311130 807 COSMIC
COSM4707000 824 COSMIC
COSM8204464 832 COSMIC
COSM1328817 833 COSMIC
COSM3410254 845 COSMIC
COSM8899542 846 COSMIC
COSM1581324 847 COSMIC
COSM1067740 853 COSMIC
COSN31568158 891 COSMIC
COSN31592476 897 COSMIC
COSN26986534 899 COSMIC
COSN30122866 900 COSMIC
COSN30129601 901 COSMIC
COSN30474807 934 COSMIC
COSN18729607 954 COSMIC
COSN30175268 954 COSMIC
COSN31600004 1065 COSMIC
COSN31600449 1104 COSMIC
COSN23745536 1112 COSMIC
COSN31541783 1130 COSMIC
COSN24300875 1131 COSMIC
COSN24301030 1132 COSMIC
COSN26564631 1197 COSMIC
COSN20101143 1330 COSMIC
COSN27241311 1330 COSMIC
COSN31517887 1366 COSMIC
COSN31555596 1455 COSMIC
COSN31529768 1517 COSMIC
COSN31547457 1520 COSMIC
COSN31483273 1537 COSMIC
COSN31596603 1592 COSMIC
COSN30389263 1624 COSMIC
COSN26670815 1645 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1373965164 11 dbSNP
rs779356219 17 dbSNP
rs1187343178 19 dbSNP
rs1422269238 22 dbSNP
rs1024197620 25 dbSNP
rs180902243 28 dbSNP
rs1481356883 33 dbSNP
rs905768832 34 dbSNP
rs1001498460 39 dbSNP
rs1197156033 39 dbSNP
rs1028052550 43 dbSNP
rs749296972 46 dbSNP
rs1270543083 55 dbSNP
rs576283345 62 dbSNP
rs983917512 63 dbSNP
rs1455857916 81 dbSNP
rs1014963532 85 dbSNP
rs1161585335 86 dbSNP
rs1305684251 86 dbSNP
rs1432146589 86 dbSNP
rs1397904589 87 dbSNP
rs543709888 91 dbSNP
rs1163038794 94 dbSNP
rs1370575371 102 dbSNP
rs1456650490 102 dbSNP
rs1413949714 103 dbSNP
rs779455302 104 dbSNP
rs76767893 105 dbSNP
rs966148017 106 dbSNP
rs919931161 108 dbSNP
rs1439491579 113 dbSNP
rs1273547723 116 dbSNP
rs1342770231 122 dbSNP
rs1353935112 125 dbSNP
rs1415863082 146 dbSNP
rs922140809 147 dbSNP
rs1349548471 154 dbSNP
rs1285894209 161 dbSNP
rs930018306 176 dbSNP
rs1335835087 184 dbSNP
rs1288130694 187 dbSNP
rs1323409571 187 dbSNP
rs15565 193 dbSNP
rs1404117130 198 dbSNP
rs1348962700 206 dbSNP
rs1226221504 207 dbSNP
rs1166147991 208 dbSNP
rs1289796252 214 dbSNP
rs1456890202 215 dbSNP
rs932205514 220 dbSNP
rs982732632 226 dbSNP
rs1161659967 229 dbSNP
rs1470523051 230 dbSNP
rs925581954 233 dbSNP
rs1198035653 242 dbSNP
rs144891615 247 dbSNP
rs944264063 249 dbSNP
rs1444072605 252 dbSNP
rs1052817555 265 dbSNP
rs1211438440 273 dbSNP
rs768199455 276 dbSNP
rs562076946 282 dbSNP
rs1471467106 293 dbSNP
rs949815883 297 dbSNP
rs1364578510 298 dbSNP
rs1045588420 317 dbSNP
rs899963266 319 dbSNP
rs1404371264 321 dbSNP
rs931720683 331 dbSNP
rs1027590050 335 dbSNP
rs1386927765 335 dbSNP
rs887735271 336 dbSNP
rs780840097 341 dbSNP
rs529260399 355 dbSNP
rs999221883 356 dbSNP
rs966094758 361 dbSNP
rs1476993844 362 dbSNP
rs1396883313 366 dbSNP
rs1412035818 367 dbSNP
rs1031068457 368 dbSNP
rs976159755 369 dbSNP
rs867519457 370 dbSNP
rs1335974392 371 dbSNP
rs1029102229 373 dbSNP
rs541434815 376 dbSNP
rs866388853 377 dbSNP
rs149040648 378 dbSNP
rs1304738194 380 dbSNP
rs1196507294 385 dbSNP
rs969154981 389 dbSNP
rs1349359769 390 dbSNP
rs973876385 394 dbSNP
rs867257527 395 dbSNP
rs935634114 403 dbSNP
rs1431725391 404 dbSNP
rs1358865201 406 dbSNP
rs988470710 406 dbSNP
rs912941227 408 dbSNP
rs1332270118 410 dbSNP
rs951447827 411 dbSNP
rs533451646 412 dbSNP
rs1174128611 413 dbSNP
rs912524435 414 dbSNP
rs1251600026 438 dbSNP
rs1388052292 443 dbSNP
rs1188095096 446 dbSNP
rs768606162 459 dbSNP
rs1427771504 460 dbSNP
rs1201246244 461 dbSNP
rs1417162872 462 dbSNP
rs1428089165 464 dbSNP
rs761875107 471 dbSNP
rs1176430002 475 dbSNP
rs1280466667 478 dbSNP
rs746239099 478 dbSNP
rs758735633 478 dbSNP
rs1356320360 482 dbSNP
rs772359728 483 dbSNP
rs1340726842 484 dbSNP
rs747291753 484 dbSNP
rs780273574 484 dbSNP
rs1303061651 485 dbSNP
rs1378906171 486 dbSNP
rs773669813 487 dbSNP
rs976028697 488 dbSNP
rs1407300481 489 dbSNP
rs768735311 490 dbSNP
rs927092454 492 dbSNP
rs1361730416 494 dbSNP
rs1213604687 499 dbSNP
rs1416879242 508 dbSNP
rs761090361 524 dbSNP
rs1356124964 532 dbSNP
rs766898203 539 dbSNP
rs201036501 540 dbSNP
rs1290420448 547 dbSNP
rs570203387 552 dbSNP
rs763443745 573 dbSNP
rs747960326 574 dbSNP
rs1172260530 576 dbSNP
rs147110911 578 dbSNP
rs1410269269 579 dbSNP
rs780857060 588 dbSNP
rs750120861 592 dbSNP
rs1187325987 594 dbSNP
rs1049415255 604 dbSNP
rs755884239 608 dbSNP
rs1443022529 609 dbSNP
rs587784052 619 dbSNP
rs727504048 621 dbSNP
rs1162934633 624 dbSNP
rs56110022 625 dbSNP
rs587784053 628 dbSNP
rs1385976396 630 dbSNP
rs1427057668 640 dbSNP
rs779883508 647 dbSNP
rs887693080 650 dbSNP
rs1043235622 653 dbSNP
rs1004793547 669 dbSNP
rs749178582 673 dbSNP
rs587784054 680 dbSNP
rs754949542 688 dbSNP
rs1289076155 689 dbSNP
rs886060561 691 dbSNP
rs1366850491 702 dbSNP
rs778802387 705 dbSNP
rs1482359516 711 dbSNP
rs186140730 712 dbSNP
rs1360836577 713 dbSNP
rs748290328 718 dbSNP
rs1359589912 723 dbSNP
rs868294395 725 dbSNP
rs772317129 728 dbSNP
rs587784055 729 dbSNP
rs797045787 729 dbSNP
rs773545402 735 dbSNP
rs747292472 748 dbSNP
rs1306011126 749 dbSNP
rs1216167378 750 dbSNP
rs797045788 750 dbSNP
rs771413945 751 dbSNP
rs587784056 753 dbSNP
rs777136404 756 dbSNP
rs759899081 766 dbSNP
rs765799258 768 dbSNP
rs1446565425 771 dbSNP
rs1157335847 774 dbSNP
rs1235333246 777 dbSNP
rs200872976 784 dbSNP
rs1401812516 787 dbSNP
rs587784057 791 dbSNP
rs139108785 792 dbSNP
rs797045789 796 dbSNP
rs750063692 805 dbSNP
rs755832194 810 dbSNP
rs1335718105 816 dbSNP
rs1382877417 819 dbSNP
rs398124474 832 dbSNP
rs1375623038 833 dbSNP
rs766097454 837 dbSNP
rs1442879930 838 dbSNP
rs753681684 840 dbSNP
rs865937237 845 dbSNP
rs997526101 846 dbSNP
rs1029099152 847 dbSNP
rs1489344626 854 dbSNP
rs587784058 863 dbSNP
rs199865449 866 dbSNP
rs1241745879 867 dbSNP
rs778876578 869 dbSNP
rs1321218495 885 dbSNP
rs1203239399 887 dbSNP
rs368337347 893 dbSNP
rs1444191607 895 dbSNP
rs1179683033 897 dbSNP
rs758539444 902 dbSNP
rs1488894388 908 dbSNP
rs1191577518 909 dbSNP
rs1470777741 909 dbSNP
rs1416730651 913 dbSNP
rs202141454 914 dbSNP
rs747157787 918 dbSNP
rs1178239272 920 dbSNP
rs1488462739 923 dbSNP
rs535124662 924 dbSNP
rs1032960059 927 dbSNP
rs553340093 928 dbSNP
rs1216001071 931 dbSNP
rs1335717527 937 dbSNP
rs1469006967 941 dbSNP
rs1307850677 945 dbSNP
rs1318773182 945 dbSNP
rs1424759506 945 dbSNP
rs587783876 945 dbSNP
rs797045744 945 dbSNP
rs1224255230 950 dbSNP
rs1366895118 955 dbSNP
rs1045428113 964 dbSNP
rs1394962286 968 dbSNP
rs905111332 970 dbSNP
rs1451214736 976 dbSNP
rs988416696 987 dbSNP
rs34031034 990 dbSNP
rs1246193844 1007 dbSNP
rs912890521 1010 dbSNP
rs886060562 1012 dbSNP
rs995322514 1015 dbSNP
rs1026750467 1018 dbSNP
rs1451891435 1019 dbSNP
rs565669720 1021 dbSNP
rs951479138 1026 dbSNP
rs773330481 1040 dbSNP
rs971066256 1055 dbSNP
rs539494562 1057 dbSNP
rs3207732 1065 dbSNP
rs1004670276 1067 dbSNP
rs1203587127 1074 dbSNP
rs1065156 1085 dbSNP
rs1487002215 1088 dbSNP
rs1261377280 1094 dbSNP
rs763005114 1097 dbSNP
rs1019611877 1099 dbSNP
rs1232713474 1099 dbSNP
rs1310523457 1106 dbSNP
rs927071035 1108 dbSNP
rs1236432093 1109 dbSNP
rs1371409559 1114 dbSNP
rs1456689117 1122 dbSNP
rs937120136 1122 dbSNP
rs1380148955 1130 dbSNP
rs1048883871 1131 dbSNP
rs909059891 1132 dbSNP
rs1036248549 1133 dbSNP
rs886060563 1133 dbSNP
rs940596624 1133 dbSNP
rs189382158 1134 dbSNP
rs901826894 1135 dbSNP
rs1161146963 1138 dbSNP
rs1176037171 1140 dbSNP
rs1455117781 1148 dbSNP
rs535770794 1149 dbSNP
rs886060564 1149 dbSNP
rs975429645 1152 dbSNP
rs1191565214 1153 dbSNP
rs1441092990 1155 dbSNP
rs1262611965 1158 dbSNP
rs1200107958 1160 dbSNP
rs750914257 1179 dbSNP
rs1282600828 1181 dbSNP
rs1212893602 1191 dbSNP
rs181989563 1204 dbSNP
rs1383882338 1211 dbSNP
rs1250537546 1216 dbSNP
rs185780527 1221 dbSNP
rs1296168186 1225 dbSNP
rs555746936 1226 dbSNP
rs1327981361 1228 dbSNP
rs1339706643 1230 dbSNP
rs1242317301 1237 dbSNP
rs1395112589 1242 dbSNP
rs968943011 1250 dbSNP
rs770949694 1253 dbSNP
rs978945187 1260 dbSNP
rs573975118 1267 dbSNP
rs1266343717 1279 dbSNP
rs924746745 1287 dbSNP
rs33999028 1292 dbSNP
rs935078610 1303 dbSNP
rs1463800313 1310 dbSNP
rs1001399386 1318 dbSNP
rs1187052583 1318 dbSNP
rs74640019 1318 dbSNP
rs768908921 1318 dbSNP
rs886060565 1318 dbSNP
rs78168072 1319 dbSNP
rs555727011 1325 dbSNP
rs1188820368 1328 dbSNP
rs1485953246 1330 dbSNP
rs1272118424 1337 dbSNP
rs1052575610 1342 dbSNP
rs541473248 1344 dbSNP
rs949108161 1348 dbSNP
rs1341149626 1350 dbSNP
rs1032493787 1351 dbSNP
rs1232281687 1356 dbSNP
rs956888174 1358 dbSNP
rs1044723891 1371 dbSNP
rs1009794818 1374 dbSNP
rs905135788 1390 dbSNP
rs1256046048 1408 dbSNP
rs1294596466 1408 dbSNP
rs1414796746 1410 dbSNP
rs775433800 1411 dbSNP
rs886060566 1415 dbSNP
rs1393678917 1419 dbSNP
rs760747084 1421 dbSNP
rs1414692920 1423 dbSNP
rs981122610 1436 dbSNP
rs1420379962 1437 dbSNP
rs926990391 1447 dbSNP
rs1231272560 1461 dbSNP
rs1418946916 1461 dbSNP
rs1179518418 1463 dbSNP
rs1439543757 1471 dbSNP
rs1250959153 1473 dbSNP
rs758917129 1475 dbSNP
rs1048223508 1480 dbSNP
rs1466976707 1485 dbSNP
rs1274598486 1487 dbSNP
rs559677890 1492 dbSNP
rs886901713 1510 dbSNP
rs35132212 1513 dbSNP
rs958464353 1514 dbSNP
rs1004044746 1517 dbSNP
rs1461654277 1518 dbSNP
rs984974584 1525 dbSNP
rs909015984 1527 dbSNP
rs1241776497 1542 dbSNP
rs940544414 1545 dbSNP
rs1020149643 1551 dbSNP
rs1439072487 1551 dbSNP
rs1157903187 1558 dbSNP
rs1385853350 1562 dbSNP
rs1397154767 1565 dbSNP
rs1454873519 1567 dbSNP
rs971918429 1589 dbSNP
rs1401401540 1590 dbSNP
rs965476191 1593 dbSNP
rs1405860358 1598 dbSNP
rs1160429965 1604 dbSNP
rs886060567 1610 dbSNP
rs933275195 1610 dbSNP
rs997278854 1618 dbSNP
rs1364244553 1627 dbSNP
rs1050449043 1632 dbSNP
rs889139224 1635 dbSNP
rs1028306517 1641 dbSNP
rs1213899318 1643 dbSNP
rs1355796977 1645 dbSNP
rs1446113962 1649 dbSNP
rs1281504707 1670 dbSNP
rs968974329 1671 dbSNP
rs1316955002 1674 dbSNP
rs1228051984 1679 dbSNP
rs1054294361 1701 dbSNP
rs978976455 1711 dbSNP
rs924776220 1719 dbSNP
rs956444146 1725 dbSNP
rs1216578590 1731 dbSNP
rs1009745639 1739 dbSNP
rs993003986 1747 dbSNP
rs1255993797 1750 dbSNP
rs190661162 1759 dbSNP
rs1343725116 1762 dbSNP
rs1025181316 1764 dbSNP
rs1401298953 1776 dbSNP
rs1401617881 1778 dbSNP
rs1172896000 1781 dbSNP
rs1482566560 1783 dbSNP
rs1213575663 1785 dbSNP
rs906780520 1788 dbSNP
rs1401729253 1789 dbSNP
rs1002891885 1790 dbSNP
rs575588206 1790 dbSNP
rs545449231 1792 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
Conditions HEK293 , HUVEC , MCF7
Location of target site CDS
Tools used in this research DIANA-microT , EIMMO , miRanda , miRBase Target Database , PicTar , TargetScan
Article - Fasanaro P; Greco S; Lorenzi M; Pescatori et al.
- The Journal of biological chemistry, 2009
miR-210 is a key player of cell response to hypoxia, modulating cell survival, VEGF-driven endothelial cell migration, and the ability of endothelial cells to form capillary-like structures. A crucial step in understanding microRNA (miRNA) function is the identification of their targets. However, only few miR-210 targets have been identified to date. Here, we describe an integrated strategy for large-scale identification of new miR-210 targets by combining transcriptomics and proteomics with bioinformatic approaches. To experimentally validate candidate targets, the RNA-induced silencing complex (RISC) loaded with miR-210 was purified by immunoprecipitation along with its mRNA targets. The complex was significantly enriched in mRNAs of 31 candidate targets, such as BDNF, GPD1L, ISCU, NCAM, and the non-coding RNA Xist. A subset of the newly identified targets was further confirmed by 3'-untranslated region (UTR) reporter assays, and hypoxia induced down-modulation of their expression was rescued blocking miR-210, providing support for the approach validity. In the case of 9 targets, such as PTPN1 and P4HB, miR-210 seed-pairing sequences localized in the coding sequence or in the 5'-UTR, in line with recent data extending miRNA targeting beyond the "classic" 3'-UTR recognition. Finally, Gene Ontology analysis of the targets highlights known miR-210 impact on cell cycle regulation and differentiation, and predicts a new role of this miRNA in RNA processing, DNA binding, development, membrane trafficking, and amino acid catabolism. Given the complexity of miRNA actions, we view such a multiprong approach as useful to adequately describe the multiple pathways regulated by miR-210 during physiopathological processes.
LinkOut: [PMID: 19826008]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
COAD -0.749 0.02 -0.762 0.01 8 Click to see details
PRAD 0.299 0.02 0.142 0.16 50 Click to see details
STAD 0.336 0.03 0.424 0.01 32 Click to see details
THCA 0.242 0.03 0.278 0.02 59 Click to see details
LUAD 0.525 0.04 0.503 0.05 12 Click to see details
BRCA -0.158 0.08 -0.152 0.08 84 Click to see details
KIRC -0.168 0.09 -0.119 0.17 68 Click to see details
LUSC 0.182 0.14 0.123 0.23 38 Click to see details
LIHC 0.144 0.16 0.144 0.16 49 Click to see details
ESCA -0.183 0.3 -0.164 0.31 11 Click to see details
HNSC -0.083 0.3 -0.149 0.17 42 Click to see details
PAAD 0.335 0.33 -0.400 0.3 4 Click to see details
KICH 0.088 0.34 0.073 0.36 25 Click to see details
CESC -0.443 0.35 -0.500 0.33 3 Click to see details
PCPG 0.423 0.36 0.500 0.33 3 Click to see details
KIRP 0.044 0.41 0.005 0.49 32 Click to see details
UCEC 0.057 0.41 0.163 0.25 19 Click to see details
CHOL -0.032 0.47 0.033 0.47 9 Click to see details
BLCA 0.002 0.5 -0.036 0.44 18 Click to see details
BLCA 0.002 0.5 -0.036 0.44 18 Click to see details
BLCA 0.002 0.5 -0.036 0.44 18 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission